Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Envafolimab in Elderly Advanced NSCLC with High PD-L1
NCT05055167Phase 2Unknown
- Sponsor
- First Affiliated Hospital of Xiamen University
- Start
- Aug 2021
- Primary completion
- Dec 2024
- Modality
- Nanobodies (VHH), Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of envafolimab in non-small cell lung cancer (NSCLC), sponsored by First Affiliated Hospital of Xiamen University. Status: unknown.
02
Drugs
envafolimab
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT05055167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05055167.